scholarly journals The tyrosine phosphatase Shp2 (PTPN11) directs Neuregulin-1/ErbB signaling throughout Schwann cell development

2009 ◽  
Vol 106 (39) ◽  
pp. 16704-16709 ◽  
Author(s):  
K. S. Grossmann ◽  
H. Wende ◽  
F. E. Paul ◽  
C. Cheret ◽  
A. N. Garratt ◽  
...  
2000 ◽  
Vol 148 (5) ◽  
pp. 1035-1046 ◽  
Author(s):  
Alistair N. Garratt ◽  
Octavian Voiculescu ◽  
Piotr Topilko ◽  
Patrick Charnay ◽  
Carmen Birchmeier

Neuregulin-1 provides an important axonally derived signal for the survival and growth of developing Schwann cells, which is transmitted by the ErbB2/ErbB3 receptor tyrosine kinases. Null mutations of the neuregulin-1, erbB2, or erbB3 mouse genes cause severe deficits in early Schwann cell development. Here, we employ Cre-loxP technology to introduce erbB2 mutations late in Schwann cell development, using a Krox20-cre allele. Cre-mediated erbB2 ablation occurs perinatally in peripheral nerves, but already at E11 within spinal roots. The mutant mice exhibit a widespread peripheral neuropathy characterized by abnormally thin myelin sheaths, containing fewer myelin wraps. In addition, in spinal roots the Schwann cell precursor pool is not correctly established. Thus, the Neuregulin signaling system functions during multiple stages of Schwann cell development and is essential for correct myelination. The thickness of the myelin sheath is determined by the axon diameter, and we suggest that trophic signals provided by the nerve determine the number of times a Schwann cell wraps an axon.


Neurosurgery ◽  
2020 ◽  
Author(s):  
Harish N Vasudevan ◽  
Calixto-Hope G Lucas ◽  
Javier E Villanueva-Meyer ◽  
Philip V Theodosopoulos ◽  
David R Raleigh

Abstract In this review, we describe Schwann cell development from embryonic neural crest cells to terminally differentiated myelinated and nonmyelinated mature Schwann cells. We focus on the genetic drivers and signaling mechanisms mediating decisions to proliferate versus differentiate during Schwann cell development, highlighting pathways that overlap with Schwann cell development and are dysregulated in tumorigenesis. We conclude by considering how our knowledge of the events underlying Schwann cell development and mouse models of schwannoma, neurofibroma, and malignant peripheral nerve sheath tumor can inform novel therapeutic strategies for patients with cancers derived from Schwann cell lineages.


PLoS ONE ◽  
2011 ◽  
Vol 6 (12) ◽  
pp. e28692 ◽  
Author(s):  
Stephan Heermann ◽  
Julia Schmücker ◽  
Ursula Hinz ◽  
Michael Rickmann ◽  
Tilmann Unterbarnscheidt ◽  
...  

Neuroscience ◽  
2016 ◽  
Vol 322 ◽  
pp. 287-297 ◽  
Author(s):  
A. Seytanoglu ◽  
N.I. Alsomali ◽  
C.F. Valori ◽  
A. McGown ◽  
H.R. Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document